Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders ...
From a Polynesian island ringed by blue lagoons to Chile's gaucho heartland, these are BBC journalists' top destinations this ...
Roivant enters new phase of corporate journey with 3+ launches, 4+ NDA/BLA filings, 8+ pivotal and 3+ proof-of-concept study readouts expected over the next three yearsHighlighting clinical execution, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback